Pulmobiotics
Pre-clinicalDevelops engineered bacteria for treating respiratory diseases like cystic fibrosis and COPD.
Founded
2019
Focus
Microbiome
About
Develops engineered bacteria for treating respiratory diseases like cystic fibrosis and COPD.
Funding History
2Total raised: $20M
Series A$15MYsios CapitalNov 15, 2023
Seed$5MCaixa Capital RiscSep 15, 2021
Company Info
TypePrivate
Founded2019
LocationBarcelona, Spain
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
A4Cell
Pre-clinical · Barcelona
Ability Pharma
Phase 2 · Barcelona
Abyntek Biopharma
Pre-clinical · Derio
Acellera
Pre-clinical · Barcelona
BeCytes Biotechnologies
Pre-clinical · Barcelona
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile